|
Tip |
objava |
| 519 |
časopis |
Poggi GL.
Compatibility of morphine tartrate admixtures in polypropylene syringes.
Aust J Hosp Pharm 1991 ; 21: 316. |
| 920 |
časopis |
Targett PL, Keefe PA, Merridew CG.
Stability of two concentrations of morphine tartrate in 10 mL polypropylene syringes.
Aust J Hosp Pharm 1997 ; 27: 452-454. |
| 980 |
časopis |
Ambados F.
Compatibility of morphine and ketamine for subcutaneous infusion.
Aust J Hosp Pharm 1995 ; 25: 352. |
| 1864 |
časopis |
Lau MH, Hackman C, Morgan DJ.
Compatibility of ketamine and morphin injections.
Pain 1998 ; 75: 389-390. |
| 2083 |
časopis |
La Forgia SP, Sharley NA, Burgess NG, Doecke CJ.
Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion.
J Pharm Pract and Res 2002 ; 32: 65-68. |
| 3474 |
Traduction Laboratorij |
Fluorouracil - Summary of Product Characteristics
Accord Healthcare Limited 2009 |
| 3504 |
Traduction Laboratorij |
Parecoxib (Dynastat®) - Summary of Product Characteristics
Pfizer 2012 |
| 3644 |
Traduction Laboratorij |
Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010 |
| 3675 |
Traduction Laboratorij |
Thiopental sodium - Summary of Product Characteristics
Archimedes Pharma UK Ltd 2015 |
| 3838 |
Traduction Laboratorij |
Magnesium Sulphate - Summary of Product Characteristics
Martindale Pharmaceuticals Ltd 2007 |
| 3934 |
Traduction Laboratorij |
Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit
GlaxoSmithKline Laboratoire 2016 |
